SDYL:ARCA-ETRACS Monthly Pay 2xLeveraged S&P Dividend ETN (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 59.78

Change

+4.01 (+7.20)%

Market Cap

USD 0.03B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks to replicate, net of expenses, the monthly compounded 2x leveraged performance of the S&P High Yield Dividend Aristocrats? Index. The index is designed the measure the performance of the 60 highest dividend yielding S&P Composite 1500 Index constituents, which have followed a managed-dividends policy of consistently increasing dividends every year for at least 25 consecutive years.

Inception Date: 22/05/2012

Primary Benchmark: DJ US Select Dividend PR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: NA%

Management Expense Ratio: 0.00 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-04-08 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

-2.15 (-5.80%)

USD 10.94B
QLD ProShares Ultra QQQ 0.95 %

-0.98 (-1.22%)

USD 5.97B
SSO ProShares Ultra S&P500 0.90 %

-0.33 (-0.47%)

USD 4.66B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

-7.19 (-2.42%)

USD 4.21B
SPXL Direxion Daily S&P500® Bull 3.. 1.00 %

-0.82 (-0.70%)

USD 4.15B
TECL Direxion Daily Technology Bull.. 1.17 %

-2.44 (-3.54%)

USD 3.23B
UPRO ProShares UltraPro S&P500 0.92 %

-0.48 (-0.78%)

USD 2.95B
FAS Direxion Daily Financial Bull .. 1.04 %

+0.93 (+1.00%)

USD 2.45B
TNA Direxion Daily Small Cap Bull .. 1.10 %

-0.20 (-0.61%)

USD 2.23B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

-3.98 (-4.33%)

USD 1.24B

ETFs Containing SDYL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -40.86% 72% C 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -40.86% 72% C 22% F
Trailing 12 Months  
Capital Gain -33.40% 73% C 31% F
Dividend Return 0.46% 32% F 8% B-
Total Return -32.94% 70% C- 29% F
Trailing 5 Years  
Capital Gain 10.21% 74% C 77% C+
Dividend Return 17.56% 86% B+ 65% D
Total Return 27.77% 80% B- 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 15.70% 97% N/A 86% B+
Dividend Return 19.03% 97% N/A 88% B+
Total Return 3.33% 89% A- 69% C-
Risk Return Profile  
Volatility (Standard Deviation) 16.92% 21% F 51% F
Risk Adjusted Return 112.43% 99% N/A 93% A
Market Capitalization 0.03B 27% F 8% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.